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restenosis and reinterventions1-4 and a significantly
lower 5-year survival compared with CABG.1,2
The improved survival of diabetic patients who
underwent CABG is limited to those who received at
least one internal thoracic artery (ITA) graft.1,5 The
superior patency rate of the ITA has led many surgeons
to use both ITAs for myocardial revascularization in an
attempt to avoid late saphenous vein closure and post-
operative return of angina. Several important studies
that appeared during the past few years reported sur-
vival benefit after bilateral ITA (BITA) compared with
single ITA grafting.6-10 However, extensive arterial
grafting with BITAs was confined mostly to nondiabet-
Agrowing number of diabetic patients with multives-sel coronary artery disease have recently been
referred for coronary artery bypass grafting (CABG)
because of an unfavorable outcome of percutaneous
transluminal coronary angioplasty.1,2 Angioplasty in
diabetic patients is associated with increased rates of
Objective: Increased risk of deep sternal infections has prohibited routine
bilateral internal thoracic artery grafting in diabetic patients. The technique
for harvesting the skeletonized internal thoracic artery provides the potential
to minimize this risk. The purpose of this study was to compare the outcome
of bypass grafting with bilateral skeletonized internal thoracic arteries in dia-
betic and nondiabetic patients.
Methods: From May 1996 to April 1998, 231 consecutive diabetic and 534
nondiabetic patients underwent bilateral skeletonized internal thoracic artery
grafting. Mean age was 66 years. Compared with the nondiabetic group, the
diabetic group comprised more women (29% vs 18%, P = .001), had a
greater prevalence of hypertension (53% vs 44%, P = .019) and congestive
heart failure (20% vs 14%, P = .016), but a lower prevalence of preoperative
acute myocardial infarction (26% vs 34%, P = .027).
Results: Operative mortality of diabetic patients was comparable with that of
nondiabetic patients (3% vs 2.6%). The two groups also had similar occur-
rences of deep sternal infection (2.6% vs 1.7%, respectively, P = .40). Deep
sternal infection was significantly more prevalent in obese, diabetic women
(3/20 = 15%) than in diabetic patients without this combination of risk fac-
tors (3/211 = 1.4%, P < .0001) (odds ratio 11.1, confidence interval 2.1-
59.4). Diabetic patients also had a higher incidence of stroke (3.5% vs 0.9%,
P = .014). Three-year actuarial survival of diabetic patients was lower
(91.3% vs 94.7%, P = .083).
Conclusions: Bilateral skeletonized internal thoracic artery grafting is a good
surgical revascularization option in diabetic patients. Operative mortality and
prevalence of sternal infection are comparable with those of nondiabetic
patients. However, the risk of sternal infection in obese diabetic women is
high, and for them we advocate the use of a single artery instead of bilateral
internal thoracic arteries. (J Thorac Cardiovasc Surg 2001;121:668-74)
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ic patients because of the increased risk of deep sternal
wound infection that was documented in patients who
underwent surgical procedures with BITA grafting.11,12
To decrease the risk of sternal infection associated
with BITA harvesting, we adopted the technique of a
skeletonizing dissection.13-15 The skeletonized artery is
isolated gently with scissors and silver clips, without the
use of cauterization. The advantage of using the ITA as a
skeletonized artery is the preservation of collateral blood
supply to the sternum, enabling more rapid healing and
decreasing the risk of infection.16 Bilateral skeletonized
ITA grafting is the preferred method for myocardial
revascularization in our service. This procedure is rou-
tinely performed in most of the patients referred for
CABG, including elderly, obese, and diabetic patients.
As of May 1996, 765 consecutive patients had under-
gone arterial revascularization with skeletonized BITA
grafts, including 231 (30%) diabetic patients. The pur-
pose of this study was to evaluate the impact of dia-
betes mellitus on early and 3-year outcome of this sub-
group by comparing it with the group of nondiabetic
patients with skeletonized BITAs.
Patients and methods
Between May 1996 and April 1998, 231 consecutive dia-
betic patients and 534 nondiabetic patients underwent CABG
with BITA grafts at the Tel-Aviv Sourasky Medical Center.
Preoperative and operative characteristic of both diabetic and
nondiabetic patients are listed in Table I. Female sex, con-
gestive heart failure (CHF), and hypertension were more
prevalent in the diabetic group than in the nondiabetic group.
However, a larger number of nondiabetic patients had acute
myocardial infarction (MI) preoperatively.
The ITAs were dissected as skeletonized arteries13 before
heparin administration to decrease the risk of damage and
hematoma formation in the region of the side branches dur-
ing dissection. The operations were performed with car-
diopulmonary bypass. The myocardial preservation tech-
nique involved intermittent infusion of warm cardioplegic
solution (30°C-32°C).17 In 45 diabetic patients (19%) and in
131 nondiabetic patients (24.5%), the right gastroepiploic
artery was used as a third arterial conduit to bypass the pos-
terior descending branch of the right coronary artery. A com-
posite graft was prepared before connection to cardiopul-
monary bypass in 478 patients (62%) (Table I). Most of the
composite grafts included end-to-side anastomosis of a free
right ITA on an in situ left ITA. When the proximal part of the
left ITA was damaged, or when its spontaneous free flow was
not sufficient, a free left ITA was anastomosed end to side to
an in situ right ITA. A third variation was the small Y-graft,
wherein a small distal section of an ITA was anastomosed
end to side to a more proximal part of the same artery.
When no graft to the posterior wall of the heart was neces-
sary (the circumflex region), the left ITA was grafted to the
left anterior descending coronary artery and the right ITA to
the right coronary artery or to its posterior descending
branch. In most cases it is impossible to reach this branch of
the right coronary artery when using the regular technique of
isolating the pedicled ITA. The skeletonized right ITA, how-
Table I. Preoperative and operative characteristics: Diabetic versus nondiabetic patients
Factor Diabetic (n = 231) Nondiabetic (n = 534) P value*
Age ≥ 70 y 72 (31.1%) 183 (34%) .45
Female sex 68 (29.4%) 99 (18%) .001
Left main stenosis 56 (24.2%) 134 (25%) .40
Acute MI > 1 wk 60 (25.9%) 182 (34%) .03
Old MI 93 (40.2%) 188 (35%) .19
Complicated PTCA 19 (8.2%) 61 (11%) .20
EF ≤ 35% 46 (19.9%) 95 (18%) .48
Congestive heart failure 47 (20.3%) 72 (14%) .02
Preoperative IABP 3 (1.29%) 20 (4%) .10
Hypertension 123 (53.2%) 235 (44%) .02
PVD 9 (5.89%) 25 (5%) .71
Chronic renal failure 19 (8.2%) 46 (9%) 1.00
Severe COPD 26 (11.2%) 48 (9%) .35
Emergency surgery 21 (9.0%) 55 (10%) .69
Repeat CABG 8 (3.4%) 14 (3%) .49
Surgical technique (composite) 159 (68.8%) 319 (60%) .02
Surgical technique (cross) 56 (24.2%) 169 (32%) .02
Use of GEA 45 (19.4%) 131 (24%) .25
Use of SVG 26 (11.2%) 64 (12%) .90
Bypass time (min) 79 ± 37 83 ± 41 .26
Crossclamp time (min) 65 ± 28 68 ± 29 .17
MI, Myocardial infarction; PTCA, percutaneous transluminal coronary angioplasty; EF, ejection fraction; IABP, intra-aortic balloon pump; PVD, pulmonary vascular
disease; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting; GEA, gastroepiploic artery; SVG, saphenous vein graft.
*Fisher exact test.
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ever, is longer and therefore can usually reach the better qual-
ity distal posterior descending artery.
To decrease the risk of spasm of the arterial grafts, we treat-
ed all patients with high-dose intravenous infusion of isosor-
bide dinitrate (Isoket) (4-20 mg/h) during the first postopera-
tive 24 to 48 hours. Systolic blood pressure was maintained
above 100 to 120 mm Hg. From the second postoperative day,
the patients were treated with calcium channel blockers (dil-
tiazem 90-180 mg/day orally) for at least 3 months.
Statistical analysis. Data are expressed as mean ± SD or
proportions as appropriate. The χ2 test was used for late
events and the Fisher exact test for the remaining discrete
variables. A 2-sample t test was used to compare discrete and
continuous variables. Multivariable logistic regression analy-
sis was used to predict unfavorable outcome events by vari-
ous risk factors. Odds ratio (OR) and 95% confidence inter-
vals (CI) are given. Postoperative survival is expressed by the
Kaplan-Meier method and survival was compared by the log
rank test. The Cox proportional hazard model was used to
evaluate risk factors for overall mortality in diabetic patients.
All analyses were performed by SPSS 9.0 software (SPSS,
Inc, Chicago, Ill).
Results
The 765 patients with skeletonized BITA grafts
received 2 to 5 (mean 3.2) grafts per patient. The average
cardiopulmonary bypass time was 79 ± 37 minutes, and
aortic crossclamping time was 65 ± 28 minutes.
Operative mortality of the 231 diabetic patients was 3%
(7 patients) (Table II), which was not significantly differ-
ent from the mortality of the 534 nondiabetic patients
with skeletonized BITA grafts (2.6%, 14 patients) (Table
II). (Operative mortality was defined as death occurring
during hospitalization for the operation, no matter how
long after the original operation the death occurred,
and/or any death within 30 days in patients who were dis-
charged from the hospital.) However, diabetic patients
had higher rates of perioperative stroke (cerebrovascular
accident [CVA] resulting in permanent neurologic
deficits and computed tomographic evidence of cerebral
infarction) (3.5% vs 0.9%, P < .05).
To determine whether the increased incidence of neu-
rologic complications was a consequence of the fact
that hypertension, CHF, and female sex were more
prevalent in this group, we performed a multivariate
analysis with diabetes as a dependent variable. We first
included the variables to be controlled as covariates
(hypertension, sex, CHF, and acute MI) and then CVA.
The logistic regression model showed that even after
controlling for these variables, the higher incidence of
CVA in diabetic patients was still statistically signifi-
cant, suggesting that the tendency toward CVA is more
pronounced in diabetic patients. This increased risk of
stroke in diabetic patients is not a consequence of other
preoperative risk factors. Moreover, after analyzing the
variables predictive of CVA, we found that diabetes
was the only variable that was predictive of CVA even
in the univariate analysis.
There were no perioperative MIs (usually defined by
the appearance of new Q waves in the electrocardiogram
associated with serum levels of creatine kinase MB frac-
tion > 50 mU/mL) among the diabetic patients (1.7%
perioperative MIs in nondiabetic patients, P < .05), and
the rates of deep sternal wound infection were similar in
the two groups (2.6% vs 1.7%, respectively).
The univariate analysis performed in the diabetic
group revealed female sex and obesity to be significant
risk factors for deep sternal infection; however, only
the combination of obesity and female sex was an inde-
pendent risk factor for this complication (OR 11.1, CI
2.1-59.4) (Table III).
Postoperative follow-up from 1 to 3 years was
available in 730 of 737 surviving patients (97%).
There were 32 (4.1%) late deaths, 8 of which were
unrelated to the operation. The 1- and 3-year actuari-
al survivals (Kaplan-Meier) of the diabetic patients
were lower than those of nondiabetic patients (94.3%
and 91.3% vs 96.2% and 94.7%, respectively).
However, the difference did not reach statistical sig-
nificance (P = .083).
Table II. Outcome events: Diabetic versus nondiabetic patients
Total group (n = 765) Diabetic (n = 231) Nondiabetic (n = 534) P value*
Operative mortality 21 (2.7%) 7 (3.0%) 14 (2.6%) .80
Three-year survival 93% ± 2% 91.3% ± 2% 94.7% ± 1% .08†
CVA 13 (1.7%) 8 (3.5%) 5 (0.9%) .014
Perioperative MI 9 (1.2%) 0 (0%) 9 (1.7%) .06
Sternal infection 15 (1.9%) 6 (2.6%) 9 (1.7%) .40
Return of angina 15 (1.9%) 4 (1.7%) 11 (2.0%) 1.00
CVA, Cerebrovascular accident; MI, myocardial infarction.
*Fisher exact test.
†Log rank test.
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None of the preoperative characteristics of the dia-
betic patients was found to be a significant predictor of
early mortality; however, univariate analysis revealed
age over 70 years, left ventricular ejection fraction less
than 35%, CHF, and emergency operation to be predic-
tors of overall (ie, combined early and late) mortality.
Older age, emergency operation, and ejection fraction
less than 35% were also found to be independent pre-
dictors in the multivariate analysis (Table IV).
Discussion
Unlike pedicled ITA harvesting, skeletonizing dissec-
tion of the ITA leaves the vein, muscle, and accompa-
nying endothoracic tissue in place. Besides preserving
collateral sternal blood supply and minimizing the risk
of deep sternal infection, the advantage here is that the
dissected artery is longer, and its spontaneous blood
flow is greater than that of the pedicled ITA,14,18 allow-
ing the use of both ITAs as grafts to almost all neces-
sary coronary vessels. No additional vein graft is
required in most cases.19
The findings in our current report do not directly
prove that sternal collateral blood supply is improved
with skeletonized ITA dissection. However, they do
strengthen the basic assumption concerning this har-
vesting technique, that it causes less damage to sternal
blood flow15,20,21 and therefore enables the use of BITA
grafts in diabetic patients. Diabetes mellitus alone was
found not to be a significant risk factor for early mor-
tality or deep sternal infection when BITAs are har-
vested as skeletonized arteries. The current study also
delineated a subgroup of diabetic patients with
increased risk of deep sternal wound infection—dia-
betic obese women. The combination of diabetes, obe-
sity, and female sex was found to be associated with a
10-fold rate of deep sternal infection (15% vs 1.4% in
diabetic patients without this combination of risk fac-
tors). Previous reports have shown obesity to be an
independent risk factor for deep sternal infection and
sternal dehiscence.11,22,23 A study by Loop and associ-
ates11 of 6504 consecutive patients having CABG iden-
tified obesity (OR 2.9) as the most important risk fac-
tor for sternal wound complications. Other risk factors
for this complication included BITA grafting, diabetes
mellitus, and old age. In another recently published
study of 11,101 CABG patients by Birkmeyer and
coworkers,23 the risk of sternal wound infection was
more than twice as high among the obese and nearly
three times higher among the severely obese CABG
patients. In view of this unacceptably high risk of ster-
Table III. Characteristics of diabetic patients and sternal wound infection
Prevalence Infection with Infection without
(n= 231) characteristic characteristic
Characteristics No. % No. % No. % P value
Age ≥ 70 y 73 31.6 1 1.3 5 3.1
Female sex 68 29.4 4 5.8 2 1.2 .043
Obesity 48 20.7 4 8.3 2 1.1 .033
Female obesity 20 8.6 3 15.0 3 1.4 .001
IDDM 14 6.0 1 7.1 5 2.3
Chronic renal failure 17 7.35 1 5.8 5 2.3
Severe COPD 26 11.25 2 7.6 4 1.9
Emergency surgery 21 9.0 1 4.7 5 2.3
Repeat CABG 7 3.0 0 0 6 2.6
IDDM, Insulin-dependent diabetes mellitus; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting.
Table IV.  Overall (early and late) mortality of diabetic patients (n = 21)
Mortality with factor Mortality without factor
Factor No. % No. % P (Cox model) HR CI
Age ≥ 70 y 12 16.4 9 5.9 .26 3.6 1.3-10.1
EF ≤ 35% 10 21.7 11 5.9 .007 5 1.8-13.7
CHF 10 20.8 11 6.0 .0035 3.1 1.9-8.7
Emergency surgery 6 28.5 15 7.1 .007 5 1.4-14
HR, Hazard ratio; CI, 95% confidence interval; EF, ejection fraction; CHF, congestive heart failure.
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nal infection, we do not advocate the use of BITA
grafts in obese diabetic women, for whom we prefer to
use single ITA and saphenous vein grafts.
We also found a 4-fold increase in the rate of post-
operative stroke in diabetic patients compared with
nondiabetic patients (3.5% vs 0.9%). Moreover, the
univariate analysis revealed diabetes mellitus to be
the only significant predictor of postoperative stroke
in the cohort of 765 patients who had CABG with
skeletonized BITAs. Similar findings were described
in diabetic patients from western Sweden, who dis-
played a higher incidence of perioperative and post-
operative neurologic complications when compared
with nondiabetic patients.24 In another report from
Emory University in Atlanta, stroke was significantly
more prevalent in patients with diabetes than in those
without diabetes (2.9% vs 1.4%, respectively,
P < .05).25
A recently published multicenter prospective study
on 2108 patients by Roach and colleagues26 reported
an incidence of 6.1% for adverse cerebral outcome
and of 3.1% for strokes (fatal and nonfatal) after
CABG. The incidence of strokes was 5 times higher
in patients with intraoperatively palpable atheroscle-
rotic plaque in the proximal aorta. In this study, dia-
betes was defined as a significant risk factor for
stroke (OR 2.46). Despite the relatively older age of
our patients (mean 66.3 years, 33% older than 70
years), the rate of postoperative stroke was slightly
lower than that in the report by Roach and associ-
ates26 (1.7% vs 3.1%). This may be explained by the
fact that complete arterial revascularization was
achieved without the use of vein grafts in 89% of our
patients. Complete arterial revascularization permits
the limitation of aortic manipulations to the neces-
sary procedures alone, that is, aortic cannulation,
insertion of cardioplegia needles, and crossclamping
of the aorta. In this technique, the ITAs are used as
the sole source of blood supply for CABG to elimi-
nate manipulation of the aorta when there is athero-
matous plaque (the “no-touch” technique).27
The diffuse and advanced nature of the atherosclerot-
ic plaques in the aorta and brain vessels of diabetic
patients is probably the most likely explanation for the
higher incidence of stroke.28,29 Another possible expla-
nation is the elevated level of β-thromboglobulin and
circulating platelet aggregates in the blood of diabetic
patients, which may reflect platelet activation and may
cause postoperative microemboli.30 Finger palpation of
the ascending aorta may underestimate the frequency
and severity of atherosclerotic plaques involving this
part of the aorta. Epiaortic or transesophageal echocar-
diography might improve intraoperative detection of
pathologic aortic plaques and thus reduce the rate of
postoperative strokes.
The midterm results of this study include up to 3
years of follow-up. Late and overall mortality rates of
patients with diabetes were higher than those of
patients without diabetes (6% and 9% vs 2.8% and
5.4%). The 3-year actuarial survival of nondiabetic
patients was better, but the difference between sur-
vivals was not significant, probably because of the rel-
atively short period of follow-up. The adverse effect of
diabetes mellitus on late survival was described by
Morris,31 Lawrie,32 Thourani,25 and their colleagues.
Our report suggests that diabetes may be an impor-
tant risk factor for late mortality at a longer follow-up
period, even in patients undergoing arterial myocardial
revascularization with BITAs. We found emergency
operation, older age, and severe left ventricular dys-
function to be predictors of late mortality in diabetic
patients.
In summary, the use of BITA grafting is an appropri-
ate surgical revascularization technique for diabetic
patients. It provides multiple arterial grafting with the
best conduits (ITAs) and at the same time is associated
with a relatively low risk of deep sternal infections. The
prevalences of early mortality and deep sternal infec-
tion in diabetic patients in this study are similar to
those of nondiabetic patients. The occurrence of peri-
operative MI in diabetic patients was low. However,
our study showed that diabetic patients have an
increased risk of stroke, which is probably related to
the diffuse character of their atherosclerotic disease.
The 3-year cumulative survival was favorable, albeit
not as good as in the nondiabetic patients. Long-term
follow-up of randomized studies comparing this surgi-
cal technique to the more conventional techniques (left
ITA plus saphenous vein graft) is needed.
Fig 1. Survival curves (Kaplan-Meier) of the diabetic and
nondiabetic study patients.
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